|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0009064,
umls-concept:C0020960,
umls-concept:C0039593,
umls-concept:C0039620,
umls-concept:C0085979,
umls-concept:C0086418,
umls-concept:C0205460,
umls-concept:C0205473,
umls-concept:C0239307,
umls-concept:C0376689,
umls-concept:C0681804,
umls-concept:C1514811,
umls-concept:C1521827,
umls-concept:C1561577,
umls-concept:C1706462
|
|
pubmed:dateCreated |
2001-11-13
|
|
pubmed:language |
eng
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:author |
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
7-11
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
|
|
pubmed:articleTitle |
Collaborative study for the establishment of a European Pharmacopoeia Biological Reference Preparation for serological potency testing of tetanus vaccines for human use: Clostridium tetani guinea pig antiserum (human).
|
|
pubmed:affiliation |
Rijksinstituut voor Volksgezondheid en Milieu, Bilthoven (NL).
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
